Strategic deals drive Catalent’s $410m move for Aptuit assets
Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
Archives for August 22, 2011
Takeda gets 24bn yen Govt grant for cell culture vacc plant
Japanese drugmaker Takeda has been awarded JPY24bn ($313m) to develop and a cell culture influenza vaccine and establish a commercial-scale production facility.